Study overturns basic tenet in leukemia biology

Findings could lead to better therapies for acute myeloid leukemia, among most difficult cancers to treat

By Joe Rojas-Burke November 18, 2019 Portland, Oregon

Downloads

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

AML research

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

AML research

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)

AML Research

Anupriya Agarwal, Ph.D., assistant professor of medicine (hematology and medical oncology) in the OHSU School of Medicine and researcher with the OHSU Knight Cancer Institute, is working to find new treatment options for those living with acute myeloid leukemia. (OHSU/Kristyna Wentz-Graff)